Clinical Trial Update: A Study to Evaluate the Irritation Potential of GSK2894512 Cream on Skin in Healthy Subjects [Phase 1]

View source ↗

Summary

A Phase 1 trial by Stiefel evaluating the skin irritation potential of GSK2894512 Cream in healthy subjects has completed, with psoriasis listed as the conditio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• GSK2894512 cream (GSK2894512)

Snippet

Sponsor: Stiefel, a GSK Company | Conditions: Psoriasis | Phase 1 | Status: COMPLETED